OTCMKTS:CORBF Global Cord Blood (CORBF) Stock Price, News & Analysis $0.95 0.00 (0.00%) As of 03:34 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartSEC FilingsShort InterestBuy This Stock About Global Cord Blood Stock (OTCMKTS:CORBF) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Global Cord Blood alerts:Sign Up Key Stats Today's Range$0.95▼$1.0050-Day Range$0.95▼$1.1052-Week Range$0.20▼$1.75Volume2,619 shsAverage Volume1,778 shsMarket Capitalization$115.47 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Global Cord Blood Corporation, traded on the New York Stock Exchange under the symbol CORBF, is a specialized provider of umbilical cord blood banking services. The company focuses on the collection, processing and long-term cryogenic storage of cord blood stem cells, which can be used for a variety of therapeutic and research applications. Its offerings include private family banking solutions as well as public and directed donation programs designed to support patients in need of hematopoietic stem cell transplants. Headquartered in Hong Kong with principal operations in Japan, Global Cord Blood serves hospitals, obstetric clinics and research institutions across the Asia-Pacific region. The company operates state-of-the-art processing laboratories and storage facilities that comply with international quality and safety standards. In addition to its core preservation services, Global Cord Blood works closely with clinical and academic partners to facilitate clinical trials, regenerative medicine research and the development of novel cell-based therapies. Founded in the early 2000s, Global Cord Blood has built a substantial repository of cord blood units, supporting both patient transplantation needs and ongoing scientific studies. The company’s management team comprises professionals with extensive backgrounds in healthcare, biotechnology and regulatory affairs, ensuring that its operations adhere to best practices in stem cell handling and biobanking. Through strategic collaborations and continuous investment in infrastructure, Global Cord Blood aims to advance the field of cellular therapies and expand access to life-saving stem cell treatments. AI Generated. May Contain Errors. Read More Receive CORBF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Global Cord Blood and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CORBF Stock News HeadlinesGlobal Cord Blood Corp.May 25 at 1:33 PM | barrons.comGlobal Cord Blood Faces Filing DelaysAugust 15, 2025 | msn.comRead this warning immediatelyPorter Stansberry, founder of one of the world's largest financial research firms, says he's breaking the biggest story of his 26-year career. A famous historian whose books have sold over 45 million copies in 65 languages is warning of a structural shift so large it has only one historical parallel - 1776. One Stanford economist calls it 'the biggest change ever - bigger than electricity, bigger than the steam engine.' Stansberry outlines the stocks to buy, the stocks to sell, and three money moves to position yourself on the right side of this shift.May 26 at 1:00 AM | Porter & Company (Ad)CORBF Global Cord Blood Corporation - Seeking AlphaJuly 3, 2025 | seekingalpha.comGlobal Cord Blood Stock Price History - Investing.comJuly 1, 2025 | investing.comAdia Med Explores International Expansion Following Global Interest in Its Innovative Umbilical Cord Blood Stem Cell TherapiesMarch 25, 2025 | finance.yahoo.comGlobal Cord Blood’s Liquidation and Court Approval UpdatesDecember 5, 2024 | markets.businessinsider.com10 Worst Performing Blue Chip Stocks in 2024October 22, 2024 | insidermonkey.comSee More Headlines CORBF Stock Analysis - Frequently Asked Questions How have CORBF shares performed this year? Global Cord Blood's stock was trading at $0.95 at the beginning of 2026. Since then, CORBF shares have increased by 0.0% and is now trading at $0.95. How do I buy shares of Global Cord Blood? Shares of CORBF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Today5/26/2026Fiscal Year End3/31/2027Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Miscellaneous health & allied services, not elsewhere classified Sub-IndustryHealthcare Current SymbolOTCMKTS:CORBF Previous SymbolNYSE:CORBF CIK1467808 Webwww.globalcordbloodcorp.com Phone852-3605-8180Fax852-3605-8181Employees1,200Year Founded2003Profitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares121,550,000Free Float120,943,000Market Cap$115.47 million OptionableNot Optionable Beta-0.80 Social Links Reduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link to learn more about using beta to protect your portfolio.Get This Free Report This page (OTCMKTS:CORBF) was last updated on 5/26/2026 by MarketBeat.com Staff. From Our PartnersHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | SponsoredYou cannot escape this realityThe last time something like this happened was 1974 - a secret deal that quietly determined the financial fate...Porter & Company | SponsoredSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | SponsoredPH: Do THESE 4 things to your bank account now …In a few short months, the US government could gain unprecedented powers over personal bank accounts - includi...Weiss Ratings | SponsoredYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...Profits Run | SponsoredElon Confirms SpaceX IPO For 6/12 [Act Now!]Elon Musk has confirmed SpaceX will IPO on Friday, June 12, 2026, at a valuation of up to $2 trillion - potent...Paradigm Press | SponsoredI was right about SpaceX. Now here's the part that mattersGoldman Sachs and JP Morgan have already been tied to allocations surrounding the SpaceX deal. When the bigges...The Oxford Club | SponsoredJune 4: The day smart money moves (not June 12)Everyone is watching June 12 - the SpaceX listing date. The real deadline is June 4, when Goldman Sachs, Morga...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Global Cord Blood Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Global Cord Blood With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
